Health Economics and Outcomes Research on-demand conference
Description
Health economic evaluation data and patient-reported outcome measurements are necessary to translate research into viable treatment options. Will your data be meaningful to industry, to payers, to regulators? Considering these factors early in the research design will set you up for success. Learn the fundamentals and how to apply them now. After attending this conference, participants will be able to:
• Discuss the fundamental principles of health economic (HE) evaluation and the measurement of patient-reported outcomes (PROMs)
• Explain the results of HE evaluations and PROMs published in peer-reviewed literature
• Identify a well-formulated HEOR research question and the data needed to answer it
• Describe the design and execution of several HE evaluation and PROMs research projects
• Summarize how patients can contribute to the research design process
Brought to you by the Professional Development and Education Committee.
Estimated duration
10 hours 15 minutes
Members-in-Training ($39.00); Members ($89.00); Nonmembers ($129.00)
Description
This conference includes presentations by:
Panelists
Speakers
- Maria Fernanda Abalem, MD, PhD, Michigan Retinal Degeneration Questionnaire -MRDQ Assistant Professor, University of Michigan, and University of Sao Paulo
- Thomas Arno Albina, MD, Economic burden of non-infectious inflammatory eye disease (NIIED) in a commercially insured population in the United States Department of Ophthalmology, School of Medicine, University of Miami
- Penny Asbell, MD, FACS, MBA, FARVO, Barrett G. Haik Endowed Chair, Professor of Ophthalmology, Department of Ophthalmology, The University of Tennessee Health Science Center, Hamilton Eye Institute
- Helen Baker, PhD, NIHR Biomedical Research Centre, Moorfields Eye Hospital NHSFT; UCL Institute of Ophthalmology
- Tasanee Braithwaite, MPH, MRCP, FRCOphthDM, Consultant Ophthalmologist, The Medical Eye Unit, Guy's and St Thomas' NHS Foundation Trust, London; Hon. Senior Lecturer, School of Life Course Sciences, King's College London
- Melissa M. Brown MD, MN, MBA,Professor of Ophthalmology, Thomas Jefferson University, Wills Eye Hospital, Philadelphia. Pa., Adjunct Professor of Ophthalmology, Emory University, Atlanta, Ga., President/CEO, Center for Value-Based Medicine, Hilton Head, S.C.
- Joshua Ehrlich, MD, MPH, Department of Ophthalmology and Visual Sciences, Institute for Social Research, University of Michigan
- Orla Galvin, BSc, PhD, Director of Research Policy at Retina International; Secretary General Board of Directors European Federation of Neurological Associations
- Vijaya Gothwal, PhD, Head, Patient-Reported Outcomes Unit - Brien Holden Eye Research Centre, L V Prasad Eye Institute, L V Prasad Marg, Banjara Hills, Hyderabad, India Marilyn James, Professor of Health Economics, Nottingham Clinical Trials Unit, School of Medicine University of Nottingham
- Jyoti Khadka, PhD, Health and Social Care Economics Group, Caring Future Institute, College of Nursing and Health Sciences, Flinders University, Adelaide, Australia; Registry of Senior Australians, South Australian Health and Medical Research Institute, Adelaide, Australia Himal Kandel, PhD, Save Sight Institute, Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia
- Ecosse Lamoureux, BEd, GradDip, MApplSc, PhD, Duke-NUS Medical School and Singapore Eye Research Institute, Singapore
- Maureen G. Maguire, PhD, Professor Emeritus, University of Pennsylvania Senior Biostatistician Jaeb Center for Health Research
- João Pedro Marques MD, MSc, FEBO, Centro Hospitalar e Universitário de Coimbra (CHUC), Coimbra, Portugal, Faculty of Medicine, University of Coimbra (FMUC), Coimbra, Portugal
- David C. Musch, PhD, MPH, Professor, Dept. of Ophthalmology and Visual Sciences, Professor, Dept. of Epidemiology, University of Michigan, Ann Arbor, Mich.
- David B. Rein, PhD, Director, Public Health Analytics Program NORC at the University of Chicago, Atlanta Office Ian Saldanha, MBBS, MPH, PhD, Center for Evidence Synthesis in Health Department of Health Services, Policy, and Practice, Department of Epidemiology, Brown University School of Public Health
- Bonnielin Swenor, PhD, MPH, Director, The Johns Hopkins Disability Health Research Center, Associate Professor, The Wilmer Eye Institute, Johns Hopkins School of Medicine
- Julio Benedicto, Vice President, Marketing and Lumevoq Operations GenSight Biologics
- Fraser Bocell, MEd, PhD, U.S. FDA/CDRH
- Lisa Keay, PhD, MPH, BOptom, School of Optometry and Vision Science, UNSW Sydney, The George Institute for Global Health, UNSW Sydney Mitchell Levine MD, MSc, FRCPC, FACP, FISPE, Assistant Dean and Professor, Dept. of Health Research Methods, Evidence & Impact, Dept. of Medicine, Div. Clinical Pharmacology & Toxicology, Faculty of Health Sciences, McMaster University
- Christopher McCabe, PhD, Institute of Health Economics
- Eric Nelson, PhD, Veteran biopharma business development, and strategic R&D planning drug discovery executive. BD consultant to Foundation Fighting Blindness, the University of North Carolina at Chapel Hill, and retina gene therapy biotechs.
- Tieuvi Nguyen, PhD, Director, Division of Ophthalmic Devices, Food and Drug Administration
- Sarah Norris, PhD, Menzies Centre for Health Policy & Economics, University of Sydney H.
- Nida Sen, MD, MHS, Clinical Professor of Ophthalmology, George Washington University, Volunteer Faculty, National Eye Institute, NIH, Senior Director, Clinical Leader, Janssen Retina
- Michelle Senchyna, PhD, Vice President, Clinical Development and Medical Affairs, Aerie Pharmaceuticals
Presentations in package:
Results 1 - 10 of 12
| Title | Credit(s) | |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| 4 | ||
| 5 | ||
| 6 | ||
| 7 | ||
| 8 | ||
| 9 | ||
| 10 |
